Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immunologix Laboratories is an independent contract research organization specializing in GLP/GCP-compliant bioanalytical and biomarker laboratory services. The company focuses on ligand binding assays, cell-based assays, qPCR, immunogenicity testing, pharmacokinetics (PK), and biomarker analysis to support the development of biologics, biosimilars, cell & gene therapies, and nucleic acid-based drugs. They integrate advanced laboratory capabilities with translational science expertise to accelerate drug development decision-making for pharmaceutical and biotechnology clients. Founded in 2012 and based in Tampa, Florida, Immunologix serves both large pharma companies and smaller enterprises globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immunologix Laboratories.